Neuropsychoanalytic Treatment of Failed Back Surgery Syndrome-Opioid Dependence

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01940588

Enrollment

Registered

2013-09-12

Start date

2012-03-31

Completion date

2013-06-30

Last updated

2015-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

Opioid Dependent Patients who have failed back surgery syndrome are detoxified and treated with a neuropsychoanalytic paradigm.

Detailed description

Patients were detoxified from opioid analgesics and treated with NSAIDs and other non-opioid analgesics, received neuropsychoanalytic therapy and low dose naltrexone. Patients kept a daily diary of: 0 - 10 pain, 0 - 10 function, hours worked, amount of alcohol drunk, illicit and licit drug use, number of health care provider appointments attended, number of self-help groups meetings attended across each of the six months of study. Six month outcomes of this approach with primary outcomes being sobriety, pain scores and function scores.

Interventions

BEHAVIORALNeuropsychoanalytic therapy

Psychotherapy, medication management

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Have failed back surgery syndrome. 2. Have evidence of Opioid Dependence by meeting DSM-IV criteria and by Drug Abuse Screening Test \> 4. (In case of a difference in these two measures, clinical staff will talk with the patient to adjudicate the difference.) 3. Over 18 4. Be able to understand spoken and written English 5. Reside within 30 miles of the site of treatment for ease of followup 6. Have health insurance or other ability to pay for treatment

Exclusion criteria

1. Homeless 2. Unable to give consent (e.g. neurological disorders, dementia, psychosis) 3. Co-occurring incapacitating psychiatric disorder such as schizophrenia 4. Pregnant 5. Financial incentive to stay ill, such as a pending disability claim 6. Member of a vulnerable population, including prisoners

Design outcomes

Primary

Measure	Time frame	Description
Improvement of pain	Six months	Detoxified patients followed for whether their pain improved.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026